Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2007 by Louisiana State University Health Sciences Center in New Orleans. Recruitment status was Recruiting

First Received on January 4, 2008. No Changes Posted

Sponsor:	Louisiana State University Health Sciences Center in New Orleans
Information provided by:	Louisiana State University Health Sciences Center in New Orleans
ClinicalTrials.gov Identifier:	NCT00596180

Purpose

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Condition	Intervention	Phase
Non-Acute Carbon Monoxide Poisoning	Drug: HBOT	Phase I

Study Type:	Interventional
Study Design:	Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Resource links provided by NLM:

MedlinePlus related topics: Carbon Monoxide Poisoning Oxygen Therapy Poisoning

Drug Information available for: Carbon monoxide

U.S. FDA Resources

Further study details as provided by Louisiana State University Health Sciences Center in New Orleans:

Primary Outcome Measures:

SPECT brain imaging [ Time Frame: after completion of HBOT ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

clinical history and physical exam [ Time Frame: after completion of HBOT ] [ Designated as safety issue: No ]

Estimated Enrollment:	30
Study Start Date:	January 2007
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: 1 HBOT	Drug: HBOT total body exposure to greater than atmospheric pressure oxygen

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion Criteria:

None.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00596180

Contacts

Contact: Paul G Harch, M.D.

504-366-1445

paulharchmd@aol.com

Locations

United States, Louisiana
Family Physicians Center	Recruiting
Marrero, Louisiana, United States, 70072
Contact: Paul G Harch, M.D. 504-366-1445 paulharchmd@aol.com
Principal Investigator: Paul G Harch, M.D.

Sponsors and Collaborators

Louisiana State University Health Sciences Center in New Orleans

Investigators

Principal Investigator:

Paul G Harch, M.D.

LSU School of Medicine

More Information

No publications provided

Responsible Party:	Paul G. Harch, M.D., LSU School of Medicine
ClinicalTrials.gov Identifier:	NCT00596180 History of Changes
Other Study ID Numbers:	LSU IRB #6626
Study First Received:	January 4, 2008
Last Updated:	January 4, 2008
Health Authority:	United States: Institutional Review Board

Keywords provided by Louisiana State University Health Sciences Center in New Orleans:

carbon monoxide poisoning
brain injury

Additional relevant MeSH terms:

Carbon Monoxide Poisoning
Poisoning
Gas Poisoning
Substance-Related Disorders

Carbon Monoxide
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 12, 2012